Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
India’s pharmaceutical sector stands at a pivotal inflection point
The export policy of all diagnostic kits and reagents (including instruments /apparatus) ... is being made free with immediate effect," the directorate general of foreign trade (DGFT) said in a notification
The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT
Subscribe To Our Newsletter & Stay Updated
